| 000 | 01123 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250512192237.0 | ||
| 264 | 0 | _c19670509 | |
| 008 | 196705s 0 0 eng d | ||
| 022 | _a0036-8075 | ||
| 024 | 7 |
_a10.1126/science.155.3770.1685 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHalpern, L M | |
| 245 | 0 | 0 |
_aFlaxedil (gallamine triethiodide): evidence for a central action. _h[electronic resource] |
| 260 |
_bScience (New York, N.Y.) _cMar 1967 |
||
| 300 |
_a1685-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlood Glucose |
| 650 | 0 | 4 | _aBlood Pressure |
| 650 | 0 | 4 | _aBody Temperature |
| 650 | 0 | 4 | _aCarbon Dioxide |
| 650 | 0 | 4 | _aCats |
| 650 | 0 | 4 |
_aCerebral Cortex _xdrug effects |
| 650 | 0 | 4 | _aElectrophysiology |
| 650 | 0 | 4 | _aEvoked Potentials |
| 650 | 0 | 4 |
_aGallamine Triethiodide _xpharmacology |
| 650 | 0 | 4 |
_aParalysis _xchemically induced |
| 700 | 1 | _aBlack, R G | |
| 773 | 0 |
_tScience (New York, N.Y.) _gvol. 155 _gno. 3770 _gp. 1685-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1126/science.155.3770.1685 _zAvailable from publisher's website |
| 999 |
_c6020512 _d6020512 |
||